ASMB Projected Dividend Yield
Assembly Biosciences Inc ( NASDAQ : ASMB )Assembly Biosciences, Inc. is a biotechnology company developing small molecule antiviral therapeutics. Its pipeline includes helicase-primase inhibitors (HPIs) for recurrent genital herpes, an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a clinical-stage capsid assembly modulator (CAM) for hepatitis B virus (HBV). The company aims for finite treatment and functional cures, with research on therapeutics for viral diseases like transplant-related herpesviruses and HBV/HDV. Key programs include ABI-6250, ABI-5366, and ABI-1179. 21 YEAR PERFORMANCE RESULTS |
ASMB Dividend History Detail ASMB Dividend News ASMB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |